Sign inGet started

Takeda Pharmaceuticals U.S.A., Inc.

Insider CIK 1716229 · OVID 10% owner · CRTX 10% owner · DAWN 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OVID Ovid Therapeutics Inc. C Conversion deriv2025-12-082025-12-091,250— $00SEC↗
OVID Ovid Therapeutics Inc. C Conversion2025-12-082025-12-091,250,000— $07,000,000SEC↗
OVID Ovid Therapeutics Inc. J Other deriv2022-07-012022-07-061,250— $01,250SEC↗
OVID Ovid Therapeutics Inc. J Other deriv2022-07-012022-07-061,250— $00SEC↗
OVID Ovid Therapeutics Inc. J Other2022-07-012022-07-065,750,000— $05,750,000SEC↗
OVID Ovid Therapeutics Inc. J Other2022-07-012022-07-065,750,000— $00SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-082021-12-09110,338$18.03 $1.99M6,120,124SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-072021-12-09128,745$18.43 $2.37M6,288,652SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-072021-12-0958,190$19.50 $1.13M6,230,462SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-062021-12-0797,692$18.05 $1.76M6,417,397SEC↗
DAWN Day One Biopharmaceuticals S Sale2021-12-032021-12-0712,517$18.47 $231.2K6,515,089SEC↗
DAWN Day One Biopharmaceuticals J Other2021-11-242021-11-2957,224— $06,527,606SEC↗
CRTX Cortexyme, Inc. C Conversion deriv2019-05-132019-05-132,360,071— $00SEC↗
CRTX Cortexyme, Inc. C Conversion deriv2019-05-132019-05-13319,731— $00SEC↗
CRTX Cortexyme, Inc. C Conversion2019-05-132019-05-132,679,802— $02,679,802SEC↗